Advances in cell-based therapy, particularly CAR-T cell therapy, have transformed the
treatment of hematological malignancies. Although an important step forward for the field …

Despite great advances in the development of modern anticancer drugs, it is still challenging
to find safer and more effective ones due to a new spectrum of diseases and emerging drug …

Cancer, characterized by the uncontrolled proliferation of aberrant cells, underscores the
imperative for innovative therapeutic approaches. Immunotherapy has emerged as a pivotal …

Hepatocellular carcinoma (HCC) is the most common type of primary hepatic cancer and is
among the major causes of mortality due to cancer. Due to the lack of efficient conventional …

Simple Summary Natural killer (NK) cells are immune cells with potent anti-tumor and anti-
infection activity. The potential benefit of NK cell therapy against chronic lymphocytic …

Natural killer (NK) cells are lymphoid cells of innate immunity that take important roles in
immune surveillance. NK cells are considered as a bridge between innate and adaptive …

Neuroblastoma is the most common extracranial pediatric solid tumor with a heterogeneous
clinical course, ranging from spontaneous regression to metastatic disease and death …

Advancements in the field of cellular immunotherapy have accelerated in recent years and
have changed the treatment landscape for a variety of hematologic malignancies. Cellular …

The isolation of a specific lymphocyte subset from blood is the required first step in the
manufacturing of many novel cellular immunotherapies. Microfluidic size-based separation …

NK cells are promising cellular therapeutics against hematological and solid malignancies.
Immunogenetic studies have identified that various activating killer cell Ig-like receptors …